BSE filing, NSE: NEOINFRA. Summary written from the filing by ALFA Finder's alert engine.
NEO Infracon Ltd: key numbers
- Share price
- ₹42.99
- Market cap
- ₹22.81 Cr
- Revenue (annual)
- ₹8.00 Cr
- Net profit (annual)
- ₹0.90 Cr
- P/E (TTM)
- 46.4×Sector 34.0×
- Promoter holding
- 62.93%+1.68% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from NEO Infracon Ltd
All →NEO Infracon Board Meeting Date
Neo Infracon intimated that its Board will meet on 3 Nov 2026 to consider Q2 FY27 results. The trading window stays closed till 5 Nov 2026.
NEO Infracon Capacity Expansion: ₹0.01 Cr Investment
Neo Infracon proposed a 54% stake in partnership firm Rubberwala & Neo Venture for Rs. 0.0054 Crore. The strategic investment targets profit-sharing in a new business line.
- Value
- ₹0.01 Cr
NEO Infracon Acquisition Worth ₹0.01 Cr
Neo Infracon's board approved a ₹54,000 investment for a 54% stake in partnership firm M/S Rubberwala & Neo Venture. The real-estate SPV deal is a related-party transaction.
- Value
- ₹0.01 Cr
NEO Infracon Board Meeting Date
Neo Infracon Limited has scheduled a board meeting for October 23, 2026. The board will consider and approve a proposed investment under Section 186.
NEO Infracon Management Change
Ms. Sonalben Kanabar has resigned as Company Secretary and Compliance Officer of Neo Infracon Limited, effective from the close of business hours on 31st October 2026.
NEO Infracon Promoter Buying
Bhavik N. Mehta, part of the promoter group, acquired 5,920 equity shares of Neo Infracon Limited via open market purchases. His stake increased by 0.14%.
- Promoter stake change
- +0.14%
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.